The association of selenium exposure with the odds of metabolic syndrome: a dose-response meta-analysis.

Abstract

Background: Selenium is a key regulator of metabolic homeostasis. It has been proposed that exposure to selenium might be associated with metabolic syndrome (MetS). However, the results are contradictory. This meta-analysis was carried out to analyze the relationships between selenium levels in biological samples and odds of Mets.

Methods: We searched Scopus and PubMed databases up until September 2024 to identify relevant studies. Odds ratio (OR) and 95% confidence interval was used to pool the data using a random effects model.

Results: The meta-analysis encompassed 18 observational studies involving 21,481 participants. It found that higher selenium exposure was related to an elevated likelihood of MetS (OR = 1.30, 95% CI = 1.12-1.51), even after controlling for covariates, such as smoking, age, alcohol consumption, and physical activity. Heterogeneity was significant among the studies (I² = 88.9%, P = 0.001). While elevated serum selenium levels linked to a higher odds of MetS, no such relationship was observed for selenium in urine or toenails. Subgroup analyses indicated that this association was evident only in females (OR = 2.0, 95% CI = 1.17-1.43) and particularly pronounced in individuals aged ≥ 50 years. A dose-response relationship was identified, showing a 6% increase in MetS odds for each additional 10 µg/L of serum selenium, with the odds rising non-linearly when serum levels surpassed 80 µg/L.

Conclusions: This study suggests that selenium may associated with the odds of MetS, following a dose-response relationship.